Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
6
×
detroit blog main
detroit top stories
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
fda
abbvie
cancer
europe blog main
europe top stories
glaxosmithkline
medical devices
novartis
vir biotechnology
allergan
amgen
biogen
What
bio
6
×
roundup
days
abbvie’s
acquisitions
advantages
ahead
alliance
announced
august
bar
biofourmis
biotech
black
brings
bristol
bucks
busy
buy
calls
cancer
celebrate
ceo
chance
changing
collabs
color
companies
continue
corner
covid
crispr
daniel
day
deal
debut
decisions
devices
diamond
diamond’s
Language
unset
6
×
Current search:
bio
×
biotech
×
" clinical trials "
×
" detroit top stories "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More